{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:17:00Z","timestamp":1790356620871,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Colorectal cancer (CRC) is the third most common cancer worldwide and a significant public health threat. Ferroptosis, an iron-dependent form of regulated cell death, has emerged as a promising therapeutic target in CRC treatment. Despite its significant clinical potential, the precise regulatory mechanisms underlying ferroptosis, particularly its role in ferroptosis within CRC, remain to be fully elucidated. Previous studies, including our own work, have revealed that various deubiquitinases (DUBs) are involved in regulating cellular processes; however, the specific mechanisms by which these enzymes contribute to ferroptosis in CRC remain unclear. In this study, we identify USP5 as a key regulator of ferroptosis in CRC. Traditionally recognized as a deubiquitinase, USP5 modulates cellular physiological activities through deubiquitination. However, our findings show that USP5, distinct from its conventional deubiquitination function, suppresses ferroptosis by promoting the lysosomal degradation of YBX3 (Y-box binding protein 3). Under normal conditions, YBX3 promotes the degradation of SLC7A11 (solute carrier family 7 member 11). However, USP5 facilitates the degradation of YBX3, leading to the stabilization of SLC7A11 and thereby promoting CRC cell survival and tumor progression. In patient-derived organoid and xenograft models, USP5 knockout significantly increased the sensitivity of cancer cells to ferroptosis and inhibited tumor growth. Moreover, additional knockout of YBX3 restored the stability of SLC7A11, highlighting the complex regulatory network between USP5, YBX3, and SLC7A11. Systematic functional assays and mechanistic studies further confirmed that the USP5\/YBX3\/SLC7A11 axis is a central pathway for ferroptosis resistance in CRC. These findings provide novel insights into therapeutic strategies for CRC, especially ferroptosis-based treatments.<\/jats:p>","DOI":"10.1038\/s41419-025-08146-2","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T15:08:20Z","timestamp":1762787300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["USP5 regulates ferroptosis in colorectal cancer by targeting the YBX3\/SLC7A11 axis through lysosomal degradation"],"prefix":"10.1038","volume":"16","author":[{"given":"Haowen","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9243-2675","authenticated-orcid":false,"given":"Haimeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanyang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7890-9781","authenticated-orcid":false,"given":"Runlei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5137-7145","authenticated-orcid":false,"given":"Xiaodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8169-0434","authenticated-orcid":false,"given":"Guoqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"8146_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"8146_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022;8:420\u201344.","journal-title":"JAMA Oncol"},{"key":"8146_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","volume":"7","author":"SG Patel","year":"2022","unstructured":"Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022;7:262\u201374.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8146_CR4","first-page":"221","volume":"46","author":"RS Zheng","year":"2024","unstructured":"Zheng RS, Chen R, Han BF, Wang SM, Li L, Sun KX, et al. [Cancer incidence and mortality in China, 2022]. Zhonghua Zhong Liu Za Zhi. 2024;46:221\u201331.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"8146_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharm Sci. 2023;44:222\u201336.","journal-title":"Trends Pharm Sci"},{"key":"8146_CR6","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.trecan.2022.06.009","volume":"8","author":"AE Pomeroy","year":"2022","unstructured":"Pomeroy AE, Schmidt EV, Sorger PK, Palmer AC. Drug independence and the curability of cancer by combination chemotherapy. Trends Cancer. 2022;8:915\u201329.","journal-title":"Trends Cancer"},{"key":"8146_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019;575:299\u2013309.","journal-title":"Nature"},{"key":"8146_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188623","volume":"1876","author":"M Luo","year":"2021","unstructured":"Luo M, Yang X, Chen HN, Nice EC, Huang C. Drug resistance in colorectal cancer: An epigenetic overview. Biochim Biophys Acta Rev Cancer. 2021;1876:188623.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8146_CR9","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/ijc.34879","volume":"154","author":"Oyelere","year":"2024","unstructured":"Oyelere, Kok DE AM, Bos D, Gunter MJ, Ferrari P, Keski-Rahkonen P, et al. Coffee consumption is associated with a reduced risk of colorectal cancer recurrence and all-cause mortality. Int J Cancer. 2024;154:2054\u201363.","journal-title":"Int J Cancer"},{"key":"8146_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"},{"key":"8146_CR11","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"8146_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41420-021-00579-w","volume":"7","author":"Y Yu","year":"2021","unstructured":"Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G, et al. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 2021;7:193.","journal-title":"Cell Death Discov"},{"key":"8146_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lu S, Wu LL, Yang L, Yang L, Wang J. The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis. 2023;14:519.","journal-title":"Cell Death Dis"},{"key":"8146_CR14","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 2019;35:830\u201349.","journal-title":"Cancer Cell"},{"key":"8146_CR15","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng J, Conrad M. The Metabolic Underpinnings of Ferroptosis. Cell Metab. 2020;32:920\u201337.","journal-title":"Cell Metab"},{"key":"8146_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8146_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23:369\u201379.","journal-title":"Cell Death Differ"},{"key":"8146_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","volume":"30","author":"Q Chen","year":"2023","unstructured":"Chen Q, Zheng W, Guan J, Liu H, Dan Y, Zhu L, et al. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell Death Differ. 2023;30:137\u201351.","journal-title":"Cell Death Differ"},{"key":"8146_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18:280\u201396.","journal-title":"Nat Rev Clin Oncol"},{"key":"8146_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115036","volume":"165","author":"X Zhou","year":"2023","unstructured":"Zhou X, An B, Lin Y, Ni Y, Zhao X, Liang X. Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies. Biomed Pharmacother. 2023;165:115036.","journal-title":"Biomed Pharmacother"},{"key":"8146_CR21","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17:2054\u201381.","journal-title":"Autophagy"},{"key":"8146_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00018-023-04907-4","volume":"80","author":"Y Ren","year":"2023","unstructured":"Ren Y, Mao X, Xu H, Dang Q, Weng S, Zhang Y, et al. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance. Cell Mol Life Sci. 2023;80:263.","journal-title":"Cell Mol Life Sci"},{"key":"8146_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307899","volume":"11","author":"X Guan","year":"2024","unstructured":"Guan X, Wang Y, Yu W, Wei Y, Lu Y, Dai E, et al. Blocking Ubiquitin-Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl-CoA Desaturase. Adv Sci (Weinh). 2024;11:e2307899.","journal-title":"Adv Sci (Weinh)"},{"key":"8146_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02030-x","volume":"23","author":"XY Zhang","year":"2024","unstructured":"Zhang XY, Li SS, Gu YR, Xiao LX, Ma XY, Chen XR, et al. CircPIAS1 promotes hepatocellular carcinoma progression by inhibiting ferroptosis via the miR-455-3p\/NUPR1\/FTH1 axis. Mol Cancer. 2024;23:113.","journal-title":"Mol Cancer"},{"key":"8146_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113524","volume":"153","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Z, Sun W, Zhang J, Xu Q, Zhou X, et al. Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets. Biomed Pharmacother. 2022;153:113524.","journal-title":"Biomed Pharmacother"},{"key":"8146_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13046-023-02925-5","volume":"43","author":"Y Hua","year":"2024","unstructured":"Hua Y, Yang S, Zhang Y, Li J, Wang M, Yeerkenbieke P, et al. Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment. J Exp Clin Cancer Res. 2024;43:19.","journal-title":"J Exp Clin Cancer Res"},{"key":"8146_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181\u201392.","journal-title":"Nat Cell Biol"},{"key":"8146_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19:405\u201314.","journal-title":"Nat Rev Cancer"},{"key":"8146_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01262-x","volume":"19","author":"T Sun","year":"2020","unstructured":"Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19:146.","journal-title":"Mol Cancer"},{"key":"8146_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104557","volume":"157","author":"F Ning","year":"2020","unstructured":"Ning F, Xin H, Liu J, Lv C, Xu X, Wang M, et al. Structure and function of USP5: Insight into physiological and pathophysiological roles. Pharmacol Res. 2020;157:104557.","journal-title":"Pharmacol Res"},{"key":"8146_CR31","doi-asserted-by":"publisher","first-page":"683.","DOI":"10.3390\/biom14060683","volume":"14","author":"J Gu","year":"2024","unstructured":"Gu J, Chen C, He P, Du Y, Zhu B. Unraveling the Immune Regulatory Functions of USP5: Implications for Disease Therapy. Biomolecules. 2024;14:683.","journal-title":"Biomolecules"},{"key":"8146_CR32","doi-asserted-by":"publisher","first-page":"e0257786","DOI":"10.1371\/journal.pone.0257786","volume":"17","author":"J Hill","year":"2022","unstructured":"Hill J, Nyathi Y. USP5 enhances SGTA mediated protein quality control. PLoS One. 2022;17:e0257786.","journal-title":"PLoS One"},{"key":"8146_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107264","volume":"300","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xue H, Jin J. Applications of protein ubiquitylation and deubiquitylation in drug discovery. J Biol Chem. 2024;300:107264.","journal-title":"J Biol Chem"},{"key":"8146_CR34","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/jcp.30686","volume":"237","author":"W Huang","year":"2022","unstructured":"Huang W, Liu X, Zhang Y, Deng M, Li G, Chen G, et al. USP5 promotes breast cancer cell proliferation and metastasis by stabilizing HIF2\u03b1. J Cell Physiol. 2022;237:2211\u20139.","journal-title":"J Cell Physiol"},{"key":"8146_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04356-6","volume":"12","author":"J Pan","year":"2021","unstructured":"Pan J, Qiao Y, Chen C, Zang H, Zhang X, Qi F, et al. USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1. Cell Death Dis. 2021;12:1051.","journal-title":"Cell Death Dis"},{"key":"8146_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03222-7","volume":"24","author":"HH Zhang","year":"2024","unstructured":"Zhang HH, Zhang AQ, Peng P, Huang L, Liu CY, Nie XR, et al. USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein. Cancer Cell Int. 2024;24:32.","journal-title":"Cancer Cell Int"},{"key":"8146_CR37","doi-asserted-by":"publisher","first-page":"jcs210856.","DOI":"10.1242\/jcs.210856","volume":"131","author":"X Xie","year":"2018","unstructured":"Xie X, Matsumoto S, Endo A, Fukushima T, Kawahara H, Saeki Y. et al. Deubiquitylases USP5 and USP13 are recruited to and regulate heat-induced stress granules through their deubiquitylating activities. J Cell Sci. 2018;131:jcs210856.","journal-title":"J Cell Sci"},{"key":"8146_CR38","doi-asserted-by":"publisher","first-page":"e0175.","DOI":"10.1097\/HC9.0000000000000193","volume":"7","author":"S Shi","year":"2023","unstructured":"Shi S, Pan X, Chen M, Zhang L, Zhang S, Wang X. et al. USP5 promotes lipopolysaccharide-induced apoptosis and inflammatory response by stabilizing the TXNIP protein. Hepatol Commun. 2023;7:e0175.","journal-title":"Hepatol Commun"},{"key":"8146_CR39","doi-asserted-by":"publisher","first-page":"50655","DOI":"10.18632\/oncotarget.16901","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Wang WM, Lu YF, Feng L, Li L, Pan MZ, et al. Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma. Oncotarget. 2017;8:50655\u201364.","journal-title":"Oncotarget"},{"key":"8146_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10506-0","volume":"23","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Wang L, Niu X, Guo Y, Zhao J, Li L, et al. EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage. BMC Cancer. 2023;23:28.","journal-title":"BMC Cancer"},{"key":"8146_CR41","doi-asserted-by":"publisher","first-page":"e84899","DOI":"10.1371\/journal.pone.0084899","volume":"9","author":"S Nakajima","year":"2014","unstructured":"Nakajima S, Lan L, Wei L, Hsieh CL, Rapi\u0107-Otrin V, Yasui A, et al. Ubiquitin-specific protease 5 is required for the efficient repair of DNA double-strand breaks. PLoS One. 2014;9:e84899.","journal-title":"PLoS One"},{"key":"8146_CR42","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1016\/j.celrep.2019.05.039","volume":"27","author":"A Cooke","year":"2019","unstructured":"Cooke A, Schwarzl T, Huppertz I, Kramer G, Mantas P, Alleaume AM, et al. The RNA-Binding Protein YBX3 Controls Amino Acid Levels by Regulating SLC mRNA Abundance. Cell Rep. 2019;27:3097\u20133106.e3095.","journal-title":"Cell Rep"},{"key":"8146_CR43","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3892\/ijmm.2016.2662","volume":"38","author":"RT Liu","year":"2016","unstructured":"Liu RT, Wang GR, Liu C, Qiu J, Yan LK, Li XJ, et al. RNAi-mediated downregulation of DNA binding protein A inhibits tumorigenesis in colorectal cancer. Int J Mol Med. 2016;38:703\u201312.","journal-title":"Int J Mol Med"},{"key":"8146_CR44","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1038\/s41388-023-02814-3","volume":"42","author":"J Xie","year":"2023","unstructured":"Xie J, Zhang H, Wang K, Ni J, Ma X, Khoury CJ, et al. M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription. Oncogene. 2023;42:2956\u201370.","journal-title":"Oncogene"},{"key":"8146_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402954","volume":"11","author":"S Ben","year":"2024","unstructured":"Ben S, Ding Z, Xin J, Li F, Cheng Y, Chen S, et al. piRNA PROPER Suppresses DUSP1 Translation by Targeting N(6)-Methyladenosine-Mediated RNA Circularization to Promote Oncogenesis of Prostate Cancer. Adv Sci (Weinh). 2024;11:e2402954.","journal-title":"Adv Sci (Weinh)"},{"key":"8146_CR46","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.21873\/anticanres.17000","volume":"44","author":"JY Jung","year":"2024","unstructured":"Jung JY, Koh SA, Lee KH. Cold-shock Domain Protein A (CSDA) Influences Hepatocyte Growth Factor-medicated Cell Proliferation and Metastasis in Gastric Cancer Cells. Anticancer Res. 2024;44:1973\u201381.","journal-title":"Anticancer Res"},{"key":"8146_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102975","volume":"69","author":"SJ Chen","year":"2024","unstructured":"Chen SJ, Zhang J, Zhou T, Rao SS, Li Q, Xiao LY, et al. Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m(5)C modification of SLC7A11 mRNA. Redox Biol. 2024;69:102975.","journal-title":"Redox Biol"},{"key":"8146_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01769-6","volume":"22","author":"J Hwang","year":"2024","unstructured":"Hwang J, Park A, Kim C, Kim CG, Kwak J, Kim B, et al. Inhibition of IRP2-dependent reprogramming of iron metabolism suppresses tumor growth in colorectal cancer. Cell Commun Signal. 2024;22:412.","journal-title":"Cell Commun Signal"},{"key":"8146_CR49","first-page":"751","volume":"17","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Ji Y, Hu N, Yu Q, Zhang X, Li J, et al. Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment. Asian J Pharm Sci. 2022;17:751\u201366.","journal-title":"Asian J Pharm Sci"},{"key":"8146_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.337","volume":"4","author":"B Yan","year":"2023","unstructured":"Yan B, Guo J, Wang Z, Ning J, Wang H, Shu L, et al. The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression. MedComm (2020). 2023;4:e337.","journal-title":"MedComm (2020)"},{"key":"8146_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116753","volume":"175","author":"L Lu","year":"2024","unstructured":"Lu L, Jifu C, Xia J, Wang J. E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases. Biomed Pharmacother. 2024;175:116753.","journal-title":"Biomed Pharmacother"},{"key":"8146_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pharmthera.2014.11.002","volume":"147","author":"P D\u2019Arcy","year":"2015","unstructured":"D\u2019Arcy P, Wang X, Linder S. Deubiquitinase inhibition as a cancer therapeutic strategy. Pharmacol Ther. 2015;147:32\u201354.","journal-title":"Pharmacol Ther"},{"key":"8146_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.psj.2024.104209","volume":"103","author":"S Han","year":"2024","unstructured":"Han S, Yu C, Qiu M, Xiong X, Peng H, Song X, et al. USP13 regulates ferroptosis in chicken follicle granulosa cells by deubiquitinating ATG7. Poult Sci. 2024;103:104209.","journal-title":"Poult Sci"},{"key":"8146_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115231","volume":"44","author":"H Chen","year":"2025","unstructured":"Chen H, Ferguson CJ, Mitchell DC, Risch I, Titus A, Paulo JA, et al. The Hao-Fountain syndrome protein USP7 regulates neuronal connectivity in the brain via a novel p53-independent ubiquitin signaling pathway. Cell Rep. 2025;44:115231.","journal-title":"Cell Rep"},{"key":"8146_CR55","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s12276-025-01433-0","volume":"57","author":"KS Hong","year":"2025","unstructured":"Hong KS, Ryu KJ, Kim H, Kim M, Park SH, Kim T. et al. MSK1 promotes colorectal cancer metastasis by increasing Snail protein stability through USP5-mediated Snail deubiquitination. Exp Mol Med. 2025;57:820\u2013835.","journal-title":"Exp Mol Med"},{"key":"8146_CR56","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1080\/15548627.2021.1965426","volume":"18","author":"B Cai","year":"2022","unstructured":"Cai B, Zhao J, Zhang Y, Liu Y, Ma C, Yi F, et al. USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3. Autophagy. 2022;18:990\u20131004.","journal-title":"Autophagy"},{"key":"8146_CR57","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2141.2010.08303.x","volume":"150","author":"R Petruzzelli","year":"2010","unstructured":"Petruzzelli R, Gaudino S, Amendola G, Sessa R, Puzone S, Di Concilio R, et al. Role of the cold shock domain protein A in the transcriptional regulation of HBG expression. Br J Haematol. 2010;150:689\u201399.","journal-title":"Br J Haematol"},{"key":"8146_CR58","first-page":"789","volume":"40","author":"M Yasen","year":"2012","unstructured":"Yasen M, Obulhasim G, Kajino K, Mogushi K, Mizushima H, Tanaka S, et al. DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue. Int J Oncol. 2012;40:789\u201397.","journal-title":"Int J Oncol"},{"key":"8146_CR59","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41418-018-0120-9","volume":"26","author":"W Pan","year":"2019","unstructured":"Pan W, Wang L, Zhang XF, Zhang H, Zhang J, Wang G, et al. Hypoxia-induced microRNA-191 contributes to hepatic ischemia\/reperfusion injury through the ZONAB\/Cyclin D1 axis. Cell Death Differ. 2019;26:291\u2013305.","journal-title":"Cell Death Differ"},{"key":"8146_CR60","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1080\/15548627.2018.1446625","volume":"14","author":"A Luciani","year":"2018","unstructured":"Luciani A, Festa BP, Chen Z, Devuyst O. Defective autophagy degradation and abnormal tight junction-associated signaling drive epithelial dysfunction in cystinosis. Autophagy. 2018;14:1157\u20139.","journal-title":"Autophagy"},{"key":"8146_CR61","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/CM9.0000000000001328","volume":"134","author":"HL Qin","year":"2021","unstructured":"Qin HL, Wang XJ, Yang BX, Du B, Yun XL. Notoginsenoside R1 attenuates breast cancer progression by targeting CCND2 and YBX3. Chin Med J (Engl). 2021;134:546\u201354.","journal-title":"Chin Med J (Engl)"},{"key":"8146_CR62","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57\u201362.","journal-title":"Nature"},{"key":"8146_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, et al. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9:55.","journal-title":"Signal Transduct Target Ther"},{"key":"8146_CR64","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond). 2022;42:88\u2013116.","journal-title":"Cancer Commun (Lond)"},{"key":"8146_CR65","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.7150\/thno.44705","volume":"10","author":"P Chen","year":"2020","unstructured":"Chen P, Li X, Zhang R, Liu S, Xiang Y, Zhang M, et al. Combinative treatment of \u03b2-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Theranostics. 2020;10:5107\u201319.","journal-title":"Theranostics"},{"key":"8146_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21:47.","journal-title":"Mol Cancer"},{"key":"8146_CR67","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s41416-023-02149-6","volume":"128","author":"H Yan","year":"2023","unstructured":"Yan H, Talty R, Aladelokun O, Bosenberg M, Johnson CH. Ferroptosis in colorectal cancer: a future target?. Br J Cancer. 2023;128:1439\u201351.","journal-title":"Br J Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08146-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08146-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08146-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T02:03:12Z","timestamp":1762826592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08146-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8146"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08146-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6569374\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Ethical Guidelines for Biomedical Research Involving Human Subjects promulgated by the National Health Commission of China. The study protocol was approved by the Institutional Review Board of the Second Affiliated Hospital, Hengyang Medical School, University of South China (Approval No. 2024085). Written informed consent was obtained from all participants prior to sample collection. Since no identifiable images of participants are included in this manuscript, additional consent for publication of images was not applicable. This study did not involve clinical trials requiring registration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"822"}}